Difloxacin antibody/antigen (BSA/OVA/KLH conjugated hapten)
anti-Difloxacin antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)
Go to Antibiotics diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-60-1 | 1. BSA-Difloxacin 2. Anti-Difloxacin mouse monoclonal antibody | $2709.00 |
GMP-SMT-60-2 | 1. OVA-Difloxacin 2. Anti-Difloxacin mouse monoclonal antibody | $2709.00 |
GMP-SMT-60-3 | 1. BSA-Difloxacin 2. Anti-Difloxacin human monoclonal antibody | $2709.00 |
GMP-SMT-60-4 | 1. OVA-Difloxacin 2. Anti-Difloxacin human monoclonal antibody | $2709.00 |
GMP-SMT-60-Ag-1 | BSA-Difloxacin | $756.00 |
GMP-SMT-60-Ag-2 | OVA-Difloxacin | $756.00 |
GMP-SMT-60-Ab-1 | Anti-Difloxacin mouse monoclonal antibody | $1953.00 |
GMP-SMT-60-Ab-2 | Anti-Difloxacin human monoclonal antibody | $1953.00 |
Size: 1mg | 10mg | 100mg
Product Description
BSA-Difloxacin
Cat No. | GMP-SMT-60-Ag-1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Difloxacin with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Difloxacin had been validated with our anti-Hapten antibody Anti-Difloxacin mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
OVA-Difloxacin
Cat No. | GMP-SMT-60-Ag-2 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates OVA-Difloxacin with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Difloxacin had been validated with our anti-Hapten antibody Anti-Difloxacin mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Difloxacin mouse monoclonal antibody
Cat No. | GMP-SMT-60-Ab-1 |
Host of Antibody | Mouse IgG |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 0.3-0.5 |
Products description | The anti-Hapten antibody against hapten Difloxacin had been validated with our hapten hapten-carrier conjugates BSA-Difloxacin via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Difloxacin human monoclonal antibody
Cat No. | GMP-SMT-60-Ab-2 |
Host of Antibody | Human IgG1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 0.3-0.5 |
Products description | The anti-Hapten antibody against hapten Difloxacin had been validated with our hapten hapten-carrier conjugates BSA-Difloxacin via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Biomarker Information
Difloxacin in Veterinary Medicine: An In-Depth Exploration
Difloxacin, a fluoroquinolone antibiotic, is a critical player in the field of veterinary medicine. Its relevance stems from its broad-spectrum antimicrobial properties, making it effective against both gram-negative and select gram-positive bacteria. In this comprehensive article, we delve into the multifaceted role of Difloxacin in veterinary practice, emphasizing the need for meticulous quantification and its impact on animal health, food safety, and antibiotic resistance.
1. Difloxacin's Role in Veterinary Medicine
Difloxacin occupies a prominent position in veterinary healthcare. Its applications extend to the treatment and prevention of bacterial infections in a wide range of animals, including livestock, poultry, and companion animals. This versatile antibiotic plays a pivotal role in maintaining animal health and productivity. Veterinarians rely on it to combat a variety of bacterial infections, which, if left untreated, could lead to severe health consequences and economic losses for livestock producers (1).
The significance of Difloxacin in veterinary medicine goes beyond individual animal health. It extends to the management of diseases affecting entire herds or flocks. In this context, Difloxacin is instrumental in preserving animal welfare and preventing the spread of contagious diseases within animal populations. As such, it has become an indispensable tool in the field of veterinary medicine (2).
2. The Challenge of Antibiotic Residues
While Difloxacin is a valuable tool for treating bacterial infections, its use raises concerns about antibiotic residues in animal-derived products such as meat, milk, and eggs. Residues of Difloxacin or its metabolites, if present in excessive amounts, can persist in these products, potentially posing risks to consumer health. Therefore, it is imperative to monitor and regulate Difloxacin usage to ensure that residues do not exceed established limits (3).
The presence of antibiotic residues in food products is a global concern, prompting regulatory agencies to establish stringent limits and monitoring programs. These limits are in place to safeguard consumer health and to prevent the emergence of antibiotic-resistant bacteria in humans, a phenomenon that can result from the consumption of animal products containing antibiotic residues (4).
3. The Imperative of Quantifying Difloxacin
Quantifying Difloxacin levels is essential for several compelling reasons:
a. Regulatory Adherence: Many countries have set maximum residue limits (MRLs) for Difloxacin and its metabolites in animal-derived food products. Precise quantification is necessary to confirm compliance with these regulations, ensuring the safety of food products and, by extension, consumer health. Failure to comply with these limits can have serious legal and economic repercussions for livestock producers (5).
b. Combating Antibiotic Resistance: The overuse or inappropriate administration of antibiotics, including Difloxacin, can contribute to the development of antibiotic-resistant bacterial strains. Monitoring Difloxacin levels is a critical tool for tracking its utilization, promoting responsible antibiotic use, and reducing the risk of antibiotic resistance. This is in line with global efforts to preserve the effectiveness of antibiotics in human and veterinary medicine (6).
c. Quality Assurance in Animal Health: Veterinarians and livestock producers rely on Difloxacin level assessments to ensure the efficacy of treatment in animals. Accurate quantification helps confirm that the antibiotic is being administered at the correct dosage and that the treatment is effectively managing bacterial infections. This is essential for maintaining the health and well-being of animals, which is not only a matter of ethical concern but also critical for sustainable livestock and poultry production (7).
d. Safe Food Supply: Consumers have a right to expect that the food they purchase is safe for consumption. Regular Difloxacin level evaluations offer assurance that animal-derived products, such as meat, milk, and eggs, are free from hazardous residues. This not only protects consumer health but also maintains trust in the safety of the food supply chain (8).
e. Advancing Research and Development: Difloxacin measurements play a crucial role in advancing scientific understanding of this antibiotic's pharmacokinetics, pharmacodynamics, and interactions with different animal species. This research is pivotal for the development of improved veterinary drugs, treatment protocols, and guidelines for the responsible use of antibiotics in veterinary medicine (9).
In summary, Difloxacin's role in veterinary medicine is multifaceted, encompassing its use as a potent antimicrobial agent in animal health management and disease prevention. The necessity for meticulous quantification of Difloxacin is driven by regulatory adherence, the need to combat antibiotic resistance, quality assurance in animal health, ensuring a safe food supply, and advancing scientific research and development in the field of veterinary pharmaceuticals. It is a vital component of the broader landscape of veterinary medicine and food safety, with far-reaching implications for both animal and human welfare.
References:
1.Veterinary Antibiotic Usage and the Development of Antibiotic Resistance in Food-Borne Pathogens. World Health Organization. Link
2.Veterinary Antimicrobial Use in the United States: An Overview. U.S. Food and Drug Administration. Link
3.Residues of Veterinary Drugs in Food: Their Potential Impact on Human Health. World Health Organization. Link
4.Veterinary Drug Residues. U.S. Food and Drug Administration. Link
5.Maximum Residue Limits (MRLs) for Veterinary Drugs in Food. World Health Organization. Link
6.Antibiotic Use in Agriculture and Its Consequential Resistance in Environmental Bacteria: A Global Challenge. Environmental Health Perspectives. Link
7.Quantitative Analysis of Veterinary Drug Residues in Food Products of Animal Origin: Meeting the Needs of Regulatory Agencies and Food Producers. Trends in Analytical Chemistry. Link
8.Ensuring the Safety of Animal-Derived Foods. World Health Organization. Link
9.Pharmacokinetics and Pharmacodynamics of Difloxacin in Poultry. Veterinary Research Communications. Link
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.